万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>五官科学

Acta Ophthalmologica(研究方向:眼科学) (官网投稿)

简介
Acta Ophthalmologica(双月刊),出版国家为丹麦。杂志出版临床和实验原始文章,评论,社论,教育照片(眼科诊​​断与治疗),病例报告和病例系列,给编辑和博士论文的信件。关键词:眼科,眼,屈光手术,视力障碍,验光等。
本刊为:SCI期刊(2015-2016), SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1755-3768

3、期刊投稿:

https://mc.manuscriptcentral.com/acta

4、信息说明:本刊信息来源于网络,包括SCI收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

201765日星期一

                      

 

Author Guidelines

 

Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo-essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor, doctoral theses.

Priority is given to high quality original papers and review articles. Manuscripts are accepted on the condition that they have not been, and will not be published elsewhere, except for abstracts of oral presentations. All submissions are subject to editorial review and will be reviewed by two or more independent reviewers, editorial board members, and guest editors. It is assumed that the author(s) has considered the ethical aspects of the study and followed the guidelines of the Helsinki Declaration, which should always be specified in the manuscript.

 

Online Only Publication

Letters to the editor are published online only from January 2010, and from January 2010 newly submitted letters to the editor will be exempt from colour charges.

 

The editor decides whether any publication is electronic only or both in print and electronic form. The authors are notified and consulted on this decision.

 

ONLINE SUBMISSION

Manuscripts to Acta Ophthalmologica should be submitted online via the journal's submission site, ScholarOne Manuscripts (formerly known as Manuscript Central). To access this system for submission and review, go directly to:

 

http://mc.manuscriptcentral.com/acta

 

Complete instructions for preparing and submitting manuscripts online are provided at the submission site. If you need assistance, please contact our support staff by phone at +1 434 817 2040 ext. 167 or via e-mail at support@scholarone.com

 

Please note that docx files are compatible with the journal submission systems.

 

ORIGINAL PAPERS

 

Arrangement of the manuscript: The manuscript should include the following: 1) title page; 2) abstract, and key words; 3) main text (introduction, materials and methods, results, discussion); 4) acknowledgement; 5) references; 6) figure and figure legends; 7) tables; 8) illustrations and graphics. For more information on manuscript format, please refer to the following guidelines.

 

1) The Title Page should contain on separate lines author(s) name, institution, and the title of the article. In addition it should contain the e-mail and postal addresses, plus telephone and fax numbers of the corresponding author. All author affiliations and corresponding authors addresses should be supplied in English.

 

2) The Abstract of original papers must be structured with the following headings: Purpose, Methods, Results, Conclusion, and should not exceed 250 words. Abstracts of review articles, perspective of ophthalmology, historical articles, case reports and case series do not have to be structured in this same way. Diagnosis/Therapy in Ophthalmology contributions, editorials and Letters to the Editor do not have an abstract, please see separate instructions below. Key Words: Four to nine key words for indexing purposes must be given.

 

3) Main text should be concise and as far as possible free of specialised language, and unnecessary or not generally accepted abbreviations. Abbreviations must be spelled out on first mention.

The following order of presentation is recommended:

Introduction stating the purpose of the article and key aspects of present knowledge. Extensive literature reviews are not desirable. Primary sources are preferred.

Material: Notice that the journal requests that all research has followed the Tenets of the Declaration of Helsinki, and that the details are provided in the manuscript text. Methods of investigation with sufficient information to permit repetition of experiments. The journal requires that authors who report on eye cancer include in their manuscript the Union for International Cancer Control / American Joint Committee on Cancer (UICC / AJCC) Tumor, Node, Metastasis (TNM) categories and stages (7th Edition) in addition to any other cancer classification scheme the authors wish to use.

 

Statistics and mathematical analyses should be applied when appropriate and be described under Methods. Authors are encouraged to take advice from an expert of statistics already when the study is designed. The following rules regarding reporting should be adhered to:

- Report proportions if the number of subjects is smaller than 10 (e.g. 2 of 5), report percentages in integers if the number of subjects is less than 100 (e.g. 34%). If the number of subjects is larger, one decimal place can be given, but is seldom necessary (e.g. 34.5%).

- Report summary statistics of normally distributed variables as mean with standard deviation, and other variable as medium with range. Use parametric and nonparametric statistical tests accordingly.

- Give exact p-values (e.g. p=0.15 and p=0.034); if p-value is smaller than 0.0001, report p - Give 95% confidence intervals for main findings.

- Mention the statistical test used with the p-value (e.g. p=0.015, paird t-test). If the same test is repeated, it does not need to be specified again.

- The statistical software used need not be referenced in the manuscript text, unless it is specific for the statistical method used (or these can be put later under a separate heading, with a pointer here).

Results should be as clearly presented as possible. Scatterplots and similar graphical presentations are often preferable to tables. Do not duplicate in the text data that is given in tables and figures.

Discussion should be based directly on the author(s)' contributions and with reference to prior investigations, pointing out the significance and the limitations of the study.

 

4) Acknowledgements should indicate the name, society and date of the meeting if an abstract of the article has been presented previously. Support for the study can also be published here. A statement regarding possible conflict of interest must be included here (e.g. disclose financial interest in the equipment or method described, research or travelling grant support, consulting services provided, or disclose absence of commercial or propriety interest).

 

5) References. The author(s) is responsible for accurate references that must conform to journal style. If references are not in journal style, the manuscript will be returned for editing without review. References in the text should quote the last name(s) of the author(s) and the year of publication: (Brown & Smith 2003) or (Brown et al. 2003) when there are three or more authors. The reference list should include only those publications cited in the text and must be listed in alphabetic order with no numbering. Initials of forenames are placed after the surname with no commas, periods or spaces between initials. All articles should be cited in the original language of the reference, not as an English translation. References 'in press' must be filled in at latest in at the proof stage. Reference to unpublished material should state the author's name followed by 'unpublished' or 'personal communications'; such references should not appear in the reference list. Titles of journals are abbreviated according to the recommendations of the Index Medicus.

 

The Wiley House Style guide provides a more details on reference management and can be accessed via Author Guidelines, here: https://authorservices.wiley.com/author-resources/Journal-Authors/Prepare/manuscript-preparation-guidelines.html

 

编委会

 

主编

纳尔·斯特凡森,雷克雅未克,冰岛

 

编辑部

主编

纳尔·斯特凡森教授

冰岛大学,国立大学医院

眼科

101雷克雅未克,冰岛

电话:+354 543 7217

传真:+354 543 4831

电邮: actaophthalmologica@hi.is

 

编辑经理

布赖迪斯·索达多尔

电话:+354 897 9752

电邮:actaophthalmologica@hi.is

 

董事会

安德斯Behndig, 瑞典

安德斯Heijl,瑞典

加斯帕Hjortdal,丹麦

贡纳尔Høvding, 挪威

NomdoM·汉松斯,荷兰

Fridbert乔纳森,冰岛

Kaarniranta , 芬兰

B. Jeroen Klevering,荷兰

Anna Midelfart,挪威

Constantin J. Pournaras ,瑞士

Jan Ulrik Prause,丹麦

Leopold Schmetterer,奥地利

Stefan Seregard, 瑞典

Hannu Uusitalo,芬兰

 

联合编辑

Anders Behndig,瑞典

Toke Bek,丹麦

Anders Heijl,瑞典

Jesper Hjortdal, 德国

TeroKivelä, 芬兰

Morten la Cour, 丹麦

Per Montan, 瑞典

 

编委会

伊丽莎白Agardh,瑞典

艾伯特·阿尔姆, 瑞典

斯滕·安德烈埃森,瑞典

克丝汀·巴格森,丹麦

苏珊妮·宾德,奥地利

拉涅达尔·布拉加多尔,挪威

斯文克拉福德,瑞典

安德鲁·迪克,英国

伊娃·达加德·科普,瑞典

丽芙·德罗尔瑟姆,挪威

哈明德·迪阿,英国

尼尔斯·埃勒斯,丹麦

Thomas Fuchsluger,德国

Thomas W. Gardner,美国

Fredrik Ghosh, 瑞典

Jakob Grauslund,丹麦

Andrzej Grzybowski ,波兰

Birgitte Haargaard,丹麦

Erling Haaskjold,挪威

Alon Harris,美国

Olav Haugen, 挪威

Steffen Heegaard,丹麦

Helena Buch Hesgaard,丹麦

Jesper Hjortdal, 丹麦

Graham Holder,英国

GerdHolmström,瑞典

GunnarHøvding, 挪威

Ilkka ImmonenFinland

Tatsuro Ishibashi,日本

马丁·J·雅格, 荷兰

GautiJóhannesson的,瑞典

乔斯特·B·霍纳斯,德国

亚希川崎,瑞士

线凯塞尔, 丹麦

菲利普·凯斯蒂林,比利时

贾恩·凯嫩,荷兰

B.杰罗恩·克弗林, 荷兰

埃里克·诺普,德国

纳迪亚·诺普,德国

加博尔·科兰,瑞典

Jorgen Krohn,挪威


投稿问答最小化  关闭